Kapil N Bhalla Selected Research

Bcl-2-Like Protein 11

1/2016	SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.
9/2015	Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kapil N Bhalla Research Topics

Disease

35	Neoplasms (Cancer) 11/2023 - 01/2002
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 08/2002
10	Breast Neoplasms (Breast Cancer) 09/2017 - 01/2002
6	Leukemia 09/2017 - 05/2009
5	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 10/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 12/2009
4	Lymphoma (Lymphomas) 01/2021 - 01/2005
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 07/2009
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 04/2002
3	Triple Negative Breast Neoplasms 07/2014 - 04/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2023 - 01/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 05/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2012 - 10/2004
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2009 - 04/2009
1	Microsatellite Instability 06/2023
1	Disease Progression 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019
1	Infections 01/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 07/2017
1	Rheumatoid Arthritis 05/2014
1	Pulmonary Edema 12/2013
1	Essential Thrombocythemia 10/2013
1	Polycythemia Vera 10/2013
1	Lung Neoplasms (Lung Cancer) 07/2013
1	Adenocarcinoma 11/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 06/2023 - 07/2003
11	Histone Deacetylase InhibitorsIBA 07/2014 - 09/2005
10	PanobinostatIBA 01/2020 - 04/2009
4	ChromatinIBA 01/2021 - 06/2005
4	Vorinostat FDA Link 09/2017 - 04/2009
4	Histones (Histone)IBA 09/2017 - 09/2009
4	Phosphotransferases (Kinase)IBA 01/2017 - 12/2011
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2011 - 07/2009
3	Transcription Factors (Transcription Factor)IBA 05/2024 - 07/2006
3	venetoclaxIBA 11/2022 - 01/2018
3	CateninsIBA 01/2021 - 01/2019
3	Bortezomib (Velcade)FDA Link 01/2020 - 01/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 05/2014 - 01/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2009 - 04/2002
2	purineIBA 04/2024 - 12/2009
2	ibrutinibIBA 01/2020 - 09/2015
2	CCAAT-Enhancer-Binding ProteinsIBA 01/2020 - 10/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2012
2	Janus KinasesIBA 01/2017 - 10/2012
2	ruxolitinibIBA 01/2017 - 10/2012
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 12/2011
2	Arsenic Trioxide (Trisenox)FDA Link 01/2016 - 04/2002
2	Bcl-2-Like Protein 11IBA 01/2016 - 09/2015
2	Cisplatin (Platino)FDA LinkGeneric 07/2014 - 10/2004
2	Decitabine FDA Link 12/2013 - 05/2009
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2013 - 07/2011
2	dactolisibIBA 05/2013 - 11/2012
2	bcr-abl Fusion ProteinsIBA 01/2011 - 05/2006
2	Endoplasmic Reticulum Chaperone BiPIBA 04/2010 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2003 - 01/2002
1	PLX51107IBA 11/2023
1	Azacitidine (5 Azacytidine)FDA Link 11/2023
1	Immune Checkpoint InhibitorsIBA 06/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022
1	Cladribine FDA LinkGeneric 11/2022
1	TransducinIBA 01/2021
1	snake venom protein C activatorIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	HomoharringtonineIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 09/2017
1	rebastinibIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	PeroxiredoxinsIBA 01/2016
1	AntioxidantsIBA 01/2016
1	Oxidants (Oxidizing Agents)IBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	Sirtuin 2IBA 01/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2014
1	veliparibIBA 07/2014
1	Oncogene Proteins (Oncogene Protein)IBA 05/2014
1	Auranofin (Ridaura)FDA Link 05/2014
1	midostaurinIBA 12/2013
1	Janus Kinase 2IBA 10/2013
1	Janus Kinase InhibitorsIBA 05/2013
1	MTOR InhibitorsIBA 05/2013
1	Beclin-1IBA 04/2013
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2013
1	moesinIBA 04/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2012
1	tozasertibIBA 09/2012
1	Aurora KinasesIBA 09/2012
1	Estrogens (Estrogen)FDA Link 04/2012
1	Chloroquine (Aralen)FDA LinkGeneric 04/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2012
1	TransferasesIBA 01/2012
1	Small Interfering RNA (siRNA)IBA 07/2011
1	nilotinib FDA Link 01/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2005
2	Induction Chemotherapy 01/2017 - 10/2004
1	Aftercare (After-Treatment) 09/2017
1	Artificial Respiration (Mechanical Ventilation) 12/2013
1	Investigational Therapies (Experimental Therapy) 10/2013